Funding
Pre-Seed · Biotech

Azulene Labs raises $3.4M pre-seed financing

Azulene Labs raised $3.4 million in pre-seed funding announced in September, with Entrada Ventures among its backers.

Updated Oct 16, 2026By RoundOS Funding desk

The company plans to expand its team and develop its product.

Its molecular simulation software applies physics-based AI to drug, materials and industrial chemistry research.

Funding history

Pre-Seed · This round$3.4M

Sources

  1. Azulene Labs Secures $3.4 Million Pre-Seed Round For Drug And Materials Simulationentradaventures.com · Sep 23, 2026
  2. startupdb.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related